John Shen
Impact in
Papers in
-
- Prostate Cancer Treatment and Research 12
- Oncology 14
- Polyomavirus and related diseases 2
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Billy W. Loo (3 shared papers)Tokihiro Yamamoto (1 shared paper)Paul Keall (1 shared paper)U. W. Langner (1 shared paper)Daniel T. Chang (2 shared papers)Albert C. Koong (2 shared papers)Terry S. Desser (1 shared paper)Karyn A. Goodman (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Journal of Clinical Oncology (3 papers)JMIR mhealth and uhealth (2 papers)Annals of Oncology (2 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
John Shen
33 papers receiving 1.0k citations
John Shen's Hit Papers
Peers
Comparison fields: 5 of 88
- Radiation 244
- Oncology 335
- Pulmonary and Respiratory Medicine 292
- Radiology, Nuclear Medicine and Imaging 166
- Cancer Research 87
Countries citing papers authored by John Shen
This map shows the geographic impact of John Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Shen more than expected).
Fields of papers citing papers by John Shen
This network shows the impact of papers produced by John Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Shen. The network helps show where John Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside John Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 312 | |
| 2 | 2008 | 225 | |
| 3 | Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC). Hit paper breakdown → | 2022 | 136 |
| 4 | 2012 | 62 | |
| 5 | 2016 | 50 | |
| 6 | 2009 | 36 | |
| 7 | 2018 | 30 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 26 | |
| 10 | 2017 | 20 | |
| 11 | 2019 | 15 | |
| 12 | 2024 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2022 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2023 | 6 | |
| 20 | 2023 | 6 |
About John Shen
John Shen is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer, Lipids, and Metabolism (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Polyomavirus and related diseases (2 papers), Cancer Treatment and Pharmacology (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Radiation (244 citations), Oncology (335 citations), Pulmonary and Respiratory Medicine (292 citations), Radiology, Nuclear Medicine and Imaging (166 citations) and Cancer Research (87 citations). John Shen has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Billy W. Loo, Tokihiro Yamamoto, Paul Keall, U. W. Langner, Daniel T. Chang, Albert C. Koong, Terry S. Desser, Karyn A. Goodman, Jeff Kim and Andrew Quon. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, JMIR mhealth and uhealth, Annals of Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.